The nation of Zimbabwe has turned down a significant American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over Washington's demand for sensitive data.
This move was revealed following a official document dated December was disclosed, which showed President Emmerson Mnangagwa felt the deal was "unbalanced".
An official representative later clarified that the US was demanding access to health data for research and profit while was not willing to guarantee the benefits from any future medical innovations.
"We must now begin the difficult and regrettable task of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for further dialogue to secure a deal acceptable to all parties so the country's critical HIV treatment initiative can continue.
Broader Context
Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a high court suspended a related health funding agreement after concerns were filed about the safety of citizens' medical information.
Since resuming office recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump stated its spending was "inefficient" and his government was pursuing direct bilateral agreements to enhance transparency and accountability.
According to reports, 16 nations in Africa have to date agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration might have yielded significant benefits for the people of Zimbabwe, especially the 1.2 million presently receiving HIV treatment via US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"Our nation was requested to provide its biological resources and data indefinitely, with no corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," Mangwana explained.
"In essence, our nation would supply the raw materials for scientific discovery with no certainty that the final treatments would be available to our people if a new pandemic emerge."
National Interest and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were upending frameworks previously established via the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.
"This mechanism is designed to ensure that when a nation provides its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to continued discussions with our US partners on how subsequent co-operation might be structured in a manner that respects the sovereignty and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that talks must proceed given that a large portion of the nation's HIV programmes relied on international support.
"Where specific concerns exist, such as those involving data governance or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group said.
The halted deal highlights the complex debate between accepting crucial international aid and protecting a country's data in an increasingly interconnected world.